Positron ships PET scanner to Japan

Article

Positron has shipped its PET scanner hardware platform, the Posicam-HZL, to the National Institute of Radiological Sciences of Japan. The equipment will be marketed and distributed by Imatron-Japan. The center will use the Posicam-HZL in oncology

Positron has shipped its PET scanner hardware platform, the Posicam-HZL, to the National Institute of Radiological Sciences of Japan. The equipment will be marketed and distributed by Imatron-Japan.

The center will use the Posicam-HZL in oncology and cardiology research, said Dr. Katsuya Yoshida of Japan's Division of Advanced Technology for Medical Imaging. Imatron-Japan president Sachiko Kinoshita said she expects interest in PET scanners to increase in that country.

Imatron, a South San Francisco-based company that creates electron beam tomography scanners, has a 16% interest in Houston-based Positron.

Positron has reported an increase in revenue for first quarter 2000 (end March 31) of 200% over the same period last year. Revenue was $1.2 million in this period compared with revenue of $388,000 for first quarter 1999. The company ascribes the increase in revenue to the shipment of one Posicam system; it did not ship any Posicam systems in the first quarter of 1999. Positron reported a net loss of $157,000 in the first quarter of 2000, which it attributed to increased staff and related operation expenditures. This was compared to net income of $34,000 in the first quarter of 1999.

Recent Videos
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Can AI Assessment of Longitudinal MRI Scans Improve Prediction for Pediatric Glioma Recurrence?
A Closer Look at MRI-Guided Adaptive Radiotherapy for Monitoring and Treating Glioblastomas
Incorporating CT Colonography into Radiology Practice
What New Research Reveals About Computed Tomography and Radiation-Induced Cancer Risk
What New Interventional Radiology Research Reveals About Treatment for Breast Cancer Liver Metastases
New Mammography Studies Assess Image-Based AI Risk Models and Breast Arterial Calcification Detection
Can Deep Learning Provide a CT-Less Alternative for Attenuation Compensation with SPECT MPI?
Related Content
© 2025 MJH Life Sciences

All rights reserved.